Recommendations for treatment of nonclassic congenital adrenal hyperplasia (NCCAH): An update

Steroids

Volumn 77, Issue 4, 2012, Pages 342-346

  Trapp, Christine M ^a   Oberfield, Sharon E ^a  

^a Och Spine at New York Presbyterian Hospitals   (United States)

Author keywords

21 Hydroxylase deficiency; Androgen excess; Hirsutism; Nonclassic congenital adrenal hyperplasia

Indexed keywords

DEXAMETHASONE; GLUCOCORTICOID; GONADORELIN DERIVATIVE; GROWTH HORMONE; HYDROCORTISONE; HYDROXYPROGESTERONE; STEROID 21 MONOOXYGENASE;

ACNE; ACNE CYSTICA; ADRENARCHE; ALOPECIA; AMBIGUOUS GENITALIA; ANDROGEN SYNTHESIS; BONE AGE; BONE DENSITY; CAUCASIAN; CHILD GROWTH; CONFERENCE PAPER; CONGENITAL ADRENAL HYPERPLASIA; DISEASE COURSE; DRUG OVERDOSE; ELECTROLYSIS; ENZYME ACTIVITY; ETHNIC GROUP; EVENING DOSAGE; FEMALE FERTILITY; GENE MUTATION; GENETIC RISK; GENITAL SYSTEM DISEASE; GROUPS BY AGE; HIRSUTISM; HUMAN; HYDROCORTISONE RELEASE; HYPERKALEMIA; HYPOALDOSTERONISM; HYPONATREMIA; INCIDENCE; INSULIN RESISTANCE; JEW; LOW DRUG DOSE; LOW LEVEL LASER THERAPY; MALE FERTILITY; MALE TYPE ALOPECIA; MENSTRUATION DISORDER; METABOLIC DISORDER; METABOLIC SYNDROME X; OBESITY; OLIGOMENORRHEA; PHENOTYPE; PRENATAL CARE; REPRODUCTION; RISK FACTOR; SALT WASTING; SHOCK; SPONTANEOUS ABORTION;

ADRENAL HYPERPLASIA, CONGENITAL; BONE DENSITY; HUMANS; METABOLIC SYNDROME X; OBESITY; REPRODUCTIVE PHYSIOLOGICAL PHENOMENA; SKIN DISEASES;

EID: 84857035949     PISSN: 0039128X     EISSN: 18785867     Source Type: Journal    
DOI: 10.1016/j.steroids.2011.12.009     Document Type: Conference Paper

References (57)

1. L.S. Levine Congenital adrenal hyperplasia Pediatr Rev 21 2000 159 170
2. A. Nordenström, S. Ahmed, and J. Jones Female preponderance in congenital adrenal hyperplasia due to CYP21 deficiency in England: implications for neonatal screening Horm Res 63 2005 22 28
3. S. Pang, and M.K. Shook Current status of neonatal screening for congenital adrenal hyperplasia Curr Opin Pediatr 9 1997 419 423 (Pubitemid 27404268)
4. B.L. Therrell Newborn screening for congenital adrenal hyperplasia Endocrinol Metab Clin North Am 30 2001 15 30 (Pubitemid 32381712)
5. H.J. van der Kamp, and J.M. Wit Neonatal screening for congenital adrenal hyperplasia Eur J Endocrinol 151 2004 U71 U75
6. N. Krone, V. Dhir, H.E. Ivison, and W. Arlt Congenital adrenal hyperplasia and P450 oxidoreductase deficiency Clin Endocrinol (Oxf) 66 2007 162 172 (Pubitemid 46098888)
7. P.C. White, and P.W. Speiser Congenital adrenal hyperplasia due to 21-hydroxylase deficiency Endocr Rev 21 2000 245 291 (Pubitemid 32275589)
8. NNSIS 2009. National Newborn Screening Information System. Available at http://www2.uthscsa.edu/nnsis.
9. S.F. Witchel, and R. Azziz Nonclassic congenital adrenal hyperplasia Int J Pediatr Endocrinol 2010 2010 625105
10. W.L. Miller Clinical review 54: genetics, diagnosis, and management of 21-hydroxylase deficiency J Clin Endocrinol Metab 78 1994 241 246
11. B. Kohn, L.S. Levine, and M.S. Pollack Late-onset steroid 21-hydroxylase deficiency: a variant of classical congenital adrenal hyperplasia J Clin Endocrinol Metab 55 1982 817 827 (Pubitemid 13054338)
12. P.W. Speiser, B. Dupont, and P. Rubinstein High frequency of nonclassical steroid 21-hydroxylase deficiency Am J Hum Genet 37 1985 650 667 (Pubitemid 16249426)
13. C. Lutfallah, W. Wang, and J.I. Mason Newly proposed hormonal criteria via genotypic proof for type II 3β-hydroxysteroid dehydrogenase deficiency J Clin Endocrinol Metab 87 2002 2611 2622 (Pubitemid 34655322)
14. K. Joehrer, S. Geley, and E.M. Strasser-Wozak CYP11B1 mutations causing non-classic adrenal hyperplasia due to 11 β -hydroxylase deficiency Hum Mol Genet 6 1997 1829 1834 (Pubitemid 27460357)
15. http://www.cypalleles.ki.se/cyp21.htm.
16. P.W. Speiser Nonclassic adrenal hyperplasia Rev Endocr Metab Disord 10 2009 77 82
17. P.W. Speiser, J. Dupont, and D. Zhu Disease expression and molecular genotype in congenital adrenal hyperplasia due to 21-hydroxylase deficiency J Clin Invest 90 1992 584 595
18. M.T. Tusie-Luna, P. Traktman, and P.C. White Determination of functional effects of mutations in the steroid 21-hydroxylase gene (CYP21) using recombinant vaccinia virus J Biol Chem 265 1990 20916 20922 (Pubitemid 120014098)
19. H. Blanché, P. Vexiau, and S. Clauin Exhaustive screening of the 21-hydroxylase gene in a population of hyperandrogenic women Hum Genet 101 1997 56 60 (Pubitemid 28014642)
20. C. Deneux, V. Tardy, and A. Dib Phenotype-genotype correlation in 56 women with nonclassical congenital adrenal hyperplasia due to 21-hydroxylase deficiency J Clin Endocrinol Metab 86 2001 207 213 (Pubitemid 32109798)
21. S. Israel, L. Weinrib, and N. Weintrob Distribution of the V281L mutation of the CYP21 gene in Israeli congenital adrenal hyperplasia patients and its associate with HLA-B14 Pediatr Endocrinol Rev 5 2006 447 450 (Pubitemid 44745402)
22. T. Shinagawa, R. Horikawa, and T. Isojima Nonclassic steroid 21-hydroxylase deficiency due to a homozygous V281L mutation in CYP21A2 detected by the neonatal mass-screening program in Japan Endocr J 54 2007 1021 1025 (Pubitemid 351346789)
23. M.T. Tusie-Luna, P.W. Speiser, and M. Dumic A mutation (Pro-30 to Leu) in CYP21 represents a potential nonclassic steroid 21-hydroxylase deficiency allele Mol Endocrinol 5 1991 685 692 (Pubitemid 21923720)
24. V. Tardy, R. Menassa, and V. Sulmont Phenotype-genotype correlations of 13 rare CYP21A2 mutations detected in 46 patients affected with 21-hydroxylase deficiency and in one carrier J Clin Endocrinol Metab 95 2010 1288 1300
25. P.C. White Neonatal screening for congenital adrenal hyperplasia Nat Rev Endocrinol 5 2009 490 498
26. R.J. Auchus Congenital adrenal hyperplasia in adults Curr Opin Endocrinol Diabetes Obes 17 2010 210 216
27. C. Moran, R. Azziz, and E. Carmina 21-hydroxylase-deficient nonclassic adrenal hyperplasia is a progressive disorder: a multicenter study Am J Obstet Gynecol 183 2000 1468 1474 (Pubitemid 32061209)
28. P.W. Speiser, E.S. Knochenhauer, and D. Dewailly A multicenter study of women with nonclassical congenital adrenal hyperplasia: relationship between genotype and phenotype Mol Genet Metab 71 2000 527 534
29. M.I. New, F. Lorenzen, and A.J. Lerner Genotyping steroid 21-hydroxylase deficiency: hormonal reference data J Clin Endocrinol Metab 57 1983 320 326 (Pubitemid 13032483)
30. H.F. Escobar-Morreale, R. Sanchón, and J.L. San Millán A prospective study of the prevalence of nonclassical congenital adrenal hyperplasia among women presenting with hyperandrogenic symptoms and signs J Clin Endocrinol Metab 93 2008 527 533 (Pubitemid 351240826)
31. C. Moran, R. Azziz, and N. Weintrob Reproductive outcome of women with 21-hydroxylase-deficient nonclassic adrenal hyperplasia J Clin Endocrinol Metab 91 2006 3451 3456 (Pubitemid 44402118)
32. R. Azziz, L.A. Hincapie, and E.S. Knochenhauer Screening for 21-hydroxylase-deficient nonclassic adrenal hyperplasia among hyperandrogenic women: a prospective study Fertil Steril 72 1999 915 925 (Pubitemid 29505460)
33. D. Dewailly, M.C. Vantyghem-Haudiquet, and C. Saidsard Clinical and biological phenotypes in late-onset 21-hydroxylase deficiency J Clin Endocrinol Metab 63 1986 418 423
34. P.W. Speiser, R. Azziz, and L.S. Baskin Congenital adrenal hyperplasia due to steroid 21-hydroxylase deficiency: an endocrine Society clinical practice guideline J Clin Endocrinol Metab 95 2010 4133 4160
35. C. Dacou-Voutetakis, and M. Dracopoulou High incidence of molecular defects of the CYP21 gene in patients with premature adrenarche J Clin Endocrinol Metab 84 1999 1570 1574 (Pubitemid 30644256)
36. J.W. Temeck, S.Y. Pang, C. Nelson, and M.I. New Genetic defects of steroidogenesis in premature pubarche J Clin Endocrinol Metab 64 1987 609 617 (Pubitemid 17020932)
37. S.E. Oberfield, A.B. Sopher, and A.T. Gerken Approach to the girl with early onset of pubic hair J Clin Endocrinol Metab 96 2011 1610 1622
38. M.I. New, J.M. Gertner, P.W. Speiser, and P. del Balzo Growth and final height in classical and non-classical 21-hydroxylase deficiency Acta Paediatr Jpn 30 1988 79 88 (Pubitemid 19047992)
39. W. Bonfig, S. Bechtold, and H. Schmidt Reduced final height outcome in congenital adrenal hyperplasia under prednisone treatment: deceleration of growth velocity during puberty J Clin Endocrinol Metab 92 2007 1635 1639 (Pubitemid 46997164)
40. H.G. Dörr Growth in patients with classic congenital adrenal hyperplasia due to 21-hydroxylase deficiency Horm Res 68 2007 93 99
41. W. Hoepffner, A. Kaufhold, H. Willgerodt, and E. Keller Patients with classic congenital adrenal hyperplasia due to 21-hydroxylase deficiency can achieve their target height: the Leipzig experience Horm Res 70 2008 42 50 (Pubitemid 351919801)
42. K. Lin-Su, M.G. Vogiatzi, and I. Marshall Treatment with growth hormone and luteinizing hormone releasing hormone analog improves final adult height in children with congenital adrenal hyperplasia J Clin Endocrinol Metab 90 2005 3318 3325 (Pubitemid 41014292)
43. E. Ludwig Classification of the types of androgenetic alopecia (common baldness) occurring in the female sex Br J Dermatol 97 1977 247 254 (Pubitemid 8208166)
44. M.E. Gonzalez, J. Cantatore-Francis, and S.J. Orlow Androgenetic alopecia in the paediatric population: a retrospective review of 57 patients Br J Dermatol 163 2010 378 385
45. K. Degitz, M. Placzek, and B. Arnold Congenital adrenal hyperplasia and acne in male patients Br J Dermatol 148 2003 1263 1266 (Pubitemid 36819231)
46. New M. Infertility and androgen excess in nonclassical 21-hydroxylase deficiency. Symposium on the Ovary: Regulation, Dysfunction and Treatment. Marco Island, 71. Jan 25-27, 1996, p.195-198.
47. E. Carmina, F. Rosato, and A. Jann Extensive clinical experience. relative prevalence of different androgen excess disorders in 950 women referred because of clinical hyperandrogenism J Clin Endocrinol Metab 91 2006 2 6 (Pubitemid 43069106)
48. W. Arlt, D.S. Willis, and S.H. Wild United Kingdom Congenital Adrenal Hyperplasia Adult Study Executive (CaHASE). Health status of adults with congenital adrenal hyperplasia: a cohort study of 203 patients J Clin Endocrinol Metab 95 2010 5110 5121
49. M. Bidet, C. Bellanné-Chantelot, and M.B. Galand-Portier Fertility in women with nonclassical congenital adrenal hyperplasia due to 21-hydroxylase deficiency J Clin Endocrinol Metab 95 2010 1182 1190
50. R. Hagenfeldt, P.O. Janson, and G. Holmdahl Fertility and pregnancy outcome in women with congenital adrenal hyperplasia due to 21-hydroxylase deficiency Hum Reprod 23 2008 1607 1612
51. A. Augarten, R. Weissenberg, C. Pariente, and J. Sack Reversible male infertility in late onset congenital adrenal hyperplasia J Endocrinol Invest 14 1991 237 240
52. I. Kalachanis, D. Rousso, and A. Kourtis Reversible infertility, pharmaceutical and spontaneous, in a male with late onset congenital adrenal hyperplasia, due to 21-hydroxylase deficiency Arch Androl 48 2002 37 41 (Pubitemid 34028376)
53. N.M. Stikkelbroeck, B.J. Otten, and A. Pasic High prevalence of testicular adrenal rest tumors, impaired spermatogenesis, and Leydig cell failure in adolescent and adult males with congenital adrenal hyperplasia J Clin Endocrinol Metab 86 2001 5721 5728 (Pubitemid 33152615)
54. T.M. Völkl, D. Simm, and A. Körner Does an altered leptin axis play a role in obesity among children and adolescents with classical congenital adrenal hyperplasia due to 21-hydroxylase deficiency? Eur J Endocrinol 160 2009 239 247
55. P.W. Speiser, J. Serrat, M.I. New, and J.M. Gertner Insulin insensitivity in adrenal hyperplasia due to nonclassical steroid 21-hydroxylase deficiency J Clin Endocrinol Metab 75 1992 1421 1424 (Pubitemid 23001395)
56. H. Falhammar, H. Filipsson, and G. Holmdahl Fractures and bone mineral density in adult women with 21-hydroxylase deficiency J Clin Endocrinol Metab 92 2007 4643 4649 (Pubitemid 350223439)
57. M.I. New Extensive clinical experience. Nonclassical 21-hydroxylase deficiency J Clin Endocrinol Metab 91 2006 4205 4214 (Pubitemid 44833386)